Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ma Yinglong Great Health is a specialized subsidiary of the Ma Yinglong Pharmaceutical Group, a venerable Chinese pharmaceutical company with a history dating back to 1582. The company focuses on the "Big Health" (Da Health) sector, leveraging the parent's historical reputation in proctology and ophthalmology to develop consumer-centric products. Its product portfolio includes functional skincare, personal care items, and health supplements, often incorporating traditional Chinese medicine (TCM) ingredients. The company is widely recognized for its "Badian" eye cream series, which was inspired by the cross-application of its famous hemorrhoid ointment for dermatological use. Ma Yinglong Great Health emphasizes a multi-channel retail strategy, with a strong presence in e-commerce and specialized health retail to bridge the gap between pharmaceutical rigor and consumer wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ma Yinglong Da Health.